A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency

Georgianne L. Arnold, Johan Van Hove, Debra Freedenberg, Arnold Strauss, Nicola Longo, Barbara Burton, Cheryl Garganta, Can Ficicioglu, Stephen Cederbaum, Cary Harding, Richard G. Boles, Dietrich Matern, Pranesh Chakraborty, Annette Feigenbaum

Research output: Contribution to journalArticle

100 Scopus citations

Abstract

Introduction: Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is a disorder of oxidation of long chain fat, and can present as cardiomyopathy or fasting intolerance in the first months to years of life, or as myopathy in later childhood to adulthood. Expanded newborn screening has identified a relatively high incidence of this disorder (1:31,500), but there is a dearth of evidence-based outcomes data to guide the development of clinical practice protocols. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for VLCAD deficiency until evidence-based guidelines are available. Method: The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Delphi was used as the consensus tool. A panel of 14 experts (including clinicians, diagnostic laboratory directors and researchers) completed three rounds of survey questions and had a face-to-face meeting. Result: Panelists reviewed the initial evaluation of the screen-positive infant, diagnostic testing and management of diagnosed patients. Grade C and D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues, particularly in the dietary management of asymptomatic infants diagnosed by newborn screening.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalMolecular Genetics and Metabolism
Volume96
Issue number3
DOIs
StatePublished - Mar 1 2009

    Fingerprint

Keywords

  • Clinical practice protocol
  • Delphi
  • Fatty acid oxidation
  • Newborn screening
  • Very long chain acyl-CoA dehydrogenase deficiency (VLCAD)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Arnold, G. L., Van Hove, J., Freedenberg, D., Strauss, A., Longo, N., Burton, B., Garganta, C., Ficicioglu, C., Cederbaum, S., Harding, C., Boles, R. G., Matern, D., Chakraborty, P., & Feigenbaum, A. (2009). A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism, 96(3), 85-90. https://doi.org/10.1016/j.ymgme.2008.09.008